Core Viewpoint - SKG, a company specializing in wearable health technology, is making its third attempt to go public by submitting an application to the Hong Kong Stock Exchange after previous failures in the A-share and North Exchange markets. This move is seen as crucial for addressing its financial challenges and transitioning from a popular brand to a technology enterprise [1][4][24]. Financial Performance - SKG's revenue has shown stagnation, with figures of 904 million RMB, 1.046 billion RMB, and 1.045 billion RMB for the years 2022 to 2024, respectively. The revenue for the first three quarters of 2025 was 878 million RMB, reflecting a 16.2% year-on-year growth, but the core business did not experience explosive growth [3][5]. - The net profit attributable to the parent company for 2022, 2023, and 2024 was 119 million RMB, 127 million RMB, and 135 million RMB, respectively, with a net profit of 106 million RMB for the first three quarters of 2025 [7][19]. Business Challenges - SKG faces multiple challenges, including a heavy reliance on its core product, the neck massager, which accounts for 44%-50% of its revenue. The company has seen a decline in revenue from other product categories, such as waist and eye massagers [13][15]. - The company's marketing-heavy approach has led to a significant drop in R&D investment, from 9.1% of revenue in 2022 to 6.6% in 2024, raising concerns about its long-term sustainability as a technology company [12][19]. Governance and Market Perception - The company's governance structure is heavily family-controlled, with over 85% of voting rights held by the founders. This has raised questions about decision-making transparency, especially in light of a controversial dividend payout of 199.4 million RMB, which exceeded the net profit for the period [8][10][19]. - SKG's reliance on a single product and aggressive marketing strategies has led to a decline in product reputation, with over 600 complaints filed against the company for issues such as product defects and misleading advertising [19][23]. Market Position and Future Outlook - Despite its challenges, SKG holds a 21.5% market share in the smart wearable health device sector in China, positioning it as a market leader. However, the company must diversify its product offerings and enhance its R&D capabilities to maintain its competitive edge [3][18]. - The upcoming IPO is seen as a critical opportunity for SKG to alleviate financial pressures and transition into a technology-focused enterprise. Success in this endeavor will depend on addressing governance issues, improving product quality, and expanding its market presence [24].